Global Supply Chain Recovery Dependent On A Vaccine
Supply Chain Shaman
APRIL 30, 2020
Glaxo SmithKline introduced Shingrix in 2017, but shortages prevailed. The global economy rebound from COVID-19 hinges on the discovery and manufacture of an effective vaccine. However, supply chain leaders well understand that drug discovery, manufacturing, and distribution are all necessary to deliver the vaccine to a willing arm.
360 
Let's personalize your content